Related Experiment Video
Updated: Jul 13, 2026
Isolation and Expansion of Human Glioblastoma Multiforme Tumor Cells Using the Neurosphere Assay
Published on: October 30, 2011
Glioblastoma multiforme and meningioma in the same patient - a case report
Jan Fortuniak1, Dariusz J Jaskólski, Marek Zawirski
1Department of Neurosurgery, Medical University of Lodz, Lodz, Poland. jfort@esculap.pl
Abstract:
We describe a case of a 64-year-old female who presented with concurrent left parietal glioblastoma multiforme and left occipital parasagittal meningioma. Both lesions were excised during the operation. There was no clinical evidence of phacomatosis. Aetiological and clinical aspects of the phenomenon are discussed.
Insights
This case study details a 64-year-old female with simultaneous glioblastoma multiforme and meningioma. Both brain tumors were surgically removed, with no signs of phacomatosis observed.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Pathology
Background:
- Concurrent brain tumors are rare, presenting diagnostic and therapeutic challenges.
- Glioblastoma multiforme and meningioma are distinct primary brain neoplasms.
- Phacomatosis encompasses a group of neurocutaneous disorders.
Observation:
- A 64-year-old female presented with symptoms necessitating investigation of the left parietal and occipital regions.
- Imaging revealed two distinct lesions: a glioblastoma multiforme in the left parietal lobe and a meningioma in the left occipital parasagittal region.
Findings:
- Surgical excision of both the glioblastoma multiforme and the meningioma was performed successfully.
- Post-operative evaluation showed no clinical indicators of phacomatosis, ruling out certain neurocutaneous syndromes.
Implications:
- This case highlights the possibility of concurrent, distinct primary brain tumors in a single patient.
- Understanding the etiological and clinical nuances of such co-occurrences is crucial for accurate diagnosis and treatment planning.
- Further research may elucidate potential shared or independent risk factors for these rare tumor combinations.
